13F Holdings
中文EN

CDXS CODEXIS, INC.

Industrial Organic Chemicals · Nasdaq · SEC CIK 1200375 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY66.9%
TTM net income YoY69.9%
TTM EPS YoY75.3%
Revenue 3-yr CAGR6.1%
Net income 3-yr CAGR—

Margins

Gross margin86.8%
Operating margin-18.3%
Net margin-21.8%
FCF margin-13.7%
EBITDA margin-12.6%

Returns

ROE-42.9%
ROA-14.3%
ROIC (approx.)-22.0%
Asset turnover0.66x

Leverage & solvency

Liabilities / assets64.5%
Debt / equity0.81x
Current ratio2.81x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.54x
Accruals ratio-6.5%
Payout ratio—
Capex / revenue1.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$70.39M$59.34M$70.14M$138.59M$104.75M
Cost of revenue$9.34M$16.29M$12.81M$38.03M$22.21M
Gross profit$61.05M$43.06M$57.33M$100.56M$82.55M
R&D expense$52.31M$46.26M$58.88M$80.10M$55.92M
SG&A expense$47.07M$55.15M$53.25M$52.17M$49.32M
Operating income-$41.74M-$58.52M-$68.07M-$34.88M-$22.70M
Pretax income-$43.93M-$65.24M-$76.17M-$33.32M-$21.09M
Income tax$47,000$34,000$69,000$276,000$189,000
Net income-$43.97M-$65.28M-$76.24M-$33.59M-$21.28M
EBITDA-$36.49M-$53.57M-$62.55M-$29.48M-$19.58M
EPS (basic)-0.50-0.89-1.12-0.51-0.33
EPS (diluted)-0.50-0.89-1.12-0.51-0.33
Weighted avg. shares (diluted)87.14M73.41M68.13M65.34M64.57M
Balance sheet
Cash & equivalents$50.79M$20.83M$65.12M$116.03M$118.89M
Short-term investments$27.42M$54.19M$0——
Receivables——$10.04M$31.90M$24.95M
Inventory$1.82M$1.80M$2.69M$2.03M$1.16M
Current assets$96.82M$98.77M$93.47M$162.89M$161.89M
PP&E, net$13.02M$14.20M$15.49M$22.61M$21.34M
Goodwill$2.46M$2.46M$2.46M$3.24M$3.24M
Total assets$147.80M$149.01M$136.56M$250.39M$246.38M
Current liabilities$25.32M$23.65M$35.83M$49.07M$33.37M
Short-term debt$0————
Long-term debt$40.10M$28.91M$0——
Total debt$40.10M$28.91M$0——
Total liabilities$97.27M$82.08M$49.95M$105.60M$81.99M
Shareholders' equity$50.53M$66.93M$86.61M$144.80M$164.39M
Net debt-$10.69M$8.08M-$65.12M——
Shares outstanding90.48M81.85M69.91M65.81M65.11M
Cash flow statement
Operating cash flow-$19.38M-$49.41M-$52.64M$11.28M-$14.27M
Capital expenditure$4.47M$4.30M$4.42M$8.31M$13.83M
Free cash flow-$23.85M-$53.72M-$57.06M$2.98M-$28.09M
Investing cash flow$23.50M-$56.98M-$4.86M-$13.58M-$21.42M
Financing cash flow$27.93M$60.52M$8.17M-$575,000$3.77M
Depreciation & amortization$5.25M$4.95M$5.52M$5.40M$3.11M
Stock-based compensation$9.62M$13.09M$9.97M$14.53M$11.59M

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.